Phuong N. Huynh

Array ( [id] => 7352241 [patent_doc_number] => 20040048340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Apoptosis inducing molecule I' [patent_app_type] => new [patent_app_number] => 10/662430 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20080 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048340.pdf [firstpage_image] =>[orig_patent_app_number] => 10662430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307413 [patent_doc_number] => 20040141969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Method for the treatment of nephritis using anti-PDGF-DD antibodies' [patent_app_type] => new [patent_app_number] => 10/665383 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29927 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141969.pdf [firstpage_image] =>[orig_patent_app_number] => 10665383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394081 [patent_doc_number] => 20040038347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Apoptosis inducing molecule I' [patent_app_type] => new [patent_app_number] => 10/662429 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20038 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038347.pdf [firstpage_image] =>[orig_patent_app_number] => 10662429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699617 [patent_doc_number] => 20060216301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Kdr peptides and vaccines containing the same' [patent_app_type] => utility [patent_app_number] => 10/527496 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 12845 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216301.pdf [firstpage_image] =>[orig_patent_app_number] => 10527496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133494 [patent_doc_number] => 20040043020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it' [patent_app_type] => new [patent_app_number] => 10/658491 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9526 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043020.pdf [firstpage_image] =>[orig_patent_app_number] => 10658491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91727 [patent_doc_number] => 07732163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Extracellular serine protease' [patent_app_type] => utility [patent_app_number] => 10/652846 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 10725 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732163.pdf [firstpage_image] =>[orig_patent_app_number] => 10652846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835592 [patent_doc_number] => 20060247424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Anti-idiotype antibody, method of constructing the anti-idiotype antibody, and method of preparing idiotype antibody using the anti-idiotype antibody' [patent_app_type] => utility [patent_app_number] => 10/525342 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4706 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247424.pdf [firstpage_image] =>[orig_patent_app_number] => 10525342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164856 [patent_doc_number] => 20040076639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Novel medicinal use of alpha antigen or alpha antigen gene' [patent_app_type] => new [patent_app_number] => 10/468456 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5311 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076639.pdf [firstpage_image] =>[orig_patent_app_number] => 10468456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230501 [patent_doc_number] => 20050079154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities' [patent_app_type] => utility [patent_app_number] => 10/640668 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11665 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079154.pdf [firstpage_image] =>[orig_patent_app_number] => 10640668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168390 [patent_doc_number] => 20050202015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue' [patent_app_type] => utility [patent_app_number] => 10/627631 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17248 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202015.pdf [firstpage_image] =>[orig_patent_app_number] => 10627631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7234435 [patent_doc_number] => 20050079613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Downregulation of cell surface glycoproteins by a family of human ubiquitin ligases' [patent_app_type] => utility [patent_app_number] => 10/624727 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24426 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079613.pdf [firstpage_image] =>[orig_patent_app_number] => 10624727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000310 [patent_doc_number] => 20070042944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Processes for the preparation of fibrinogen' [patent_app_type] => utility [patent_app_number] => 10/520436 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8496 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042944.pdf [firstpage_image] =>[orig_patent_app_number] => 10520436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7358763 [patent_doc_number] => 20040014145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Carbohydrate deficient transferrin (CDT) -specific antibodies, their preparation and use' [patent_app_type] => new [patent_app_number] => 10/612162 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5516 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014145.pdf [firstpage_image] =>[orig_patent_app_number] => 10612162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743157 [patent_doc_number] => 20060088882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Methods for the treatment or prevention of obesity' [patent_app_type] => utility [patent_app_number] => 10/519248 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12172 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088882.pdf [firstpage_image] =>[orig_patent_app_number] => 10519248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334574 [patent_doc_number] => 20040132049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method for the detection of apoptosis' [patent_app_type] => new [patent_app_number] => 10/607455 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14041 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132049.pdf [firstpage_image] =>[orig_patent_app_number] => 10607455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725528 [patent_doc_number] => 20030207840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Genes induced by hypoxia' [patent_app_type] => new [patent_app_number] => 10/465572 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9147 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207840.pdf [firstpage_image] =>[orig_patent_app_number] => 10465572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256163 [patent_doc_number] => 20040259822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Immunovectors which can be used for the intracellular and intranuclear transport' [patent_app_type] => new [patent_app_number] => 10/465654 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7897 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259822.pdf [firstpage_image] =>[orig_patent_app_number] => 10465654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679151 [patent_doc_number] => 07083790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Extracellular serine protease' [patent_app_type] => utility [patent_app_number] => 10/461787 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 11187 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083790.pdf [firstpage_image] =>[orig_patent_app_number] => 10461787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6824961 [patent_doc_number] => 20030235583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Combined use of a modulator of CD3 and a beta cell resting compound' [patent_app_type] => new [patent_app_number] => 10/458900 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10087 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235583.pdf [firstpage_image] =>[orig_patent_app_number] => 10458900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664124 [patent_doc_number] => 20030203450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'STRL33, a human fusion accessory factor associated with HIV infection' [patent_app_type] => new [patent_app_number] => 10/458110 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17774 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203450.pdf [firstpage_image] =>[orig_patent_app_number] => 10458110 [rel_patent_id] =>[rel_patent_doc_number] =>)